Table 2.
Antioxidant | Study type | Specie | Dose used | Outcome | Reference |
---|---|---|---|---|---|
GSH | In-vitro | Donkey | 0, 2, 4, 6, 8, 10 mM | Significantly higher motility & kinematic parameters Higher sperm viability |
[59] |
In-vivo | Human | 600 mg | Significantly improved fertility | [60] | |
Reduced GSH & SOD | In-vitro | Bull | GSH: 5, 7.5 mM SOD: 50, 100 U/mL |
Improved total and progressive motility parameters | [61] |
Cysteine | In-vivo | Human | 600 mg | Significantly improved sperm count and motility Significantly decreased abnormal morphology DNA fragmentation and protamine deficiency |
[63] |
In-vitro | Human | 1.0 mg/mL | Significantly improved sperm function and motility Significantly decreased ROS production |
[64] | |
Buffalo | 0.0, 0.5, 1.0, 2.0, 3.0 mM | Improved antioxidant status, freeze-thaw quality, and in-vivo fertility | [65] | ||
Cysteine & SOD | In-vitro | Chicken | 5 mM 200 U/mL |
Prevented the reduction in motility, viability, and mitochondrial membrane potential Protected sperm against apoptotic changes |
[66] |
Cysteine & Erythioneine | In-vitro | Ram | 0, 1, 2, 4 mM | Improved freeze-thaw sperm motility and mitochondrial activity | [67] |
Vitamin C | In-vivo | Human | 5, 10, 20, 60, 250 mg/d | Reduced oxidative DNA damage of sperm | [68] |
50, 100, 200, 400, 800, 1,000, 2,000, 4,000 μg | Improved sperm motility and viability through reduced ROS production | [73] | |||
0, 200, 1,000 mg/d | Improved sperm quality | [69] | |||
1,000 mg/d | Significant rise in sperm count, sperm motility, and sperm with normal morphology | [70] | |||
500 mg/d | Improved sperm motility and morphology | [71] | |||
Rat | 25 mg/kg/d | Protective role on cyclophosphamide-induced testicular dysfunction Alleviates the cyclophosphamide-induced OS |
[72] | ||
0.88 mg/kg | Higher sperm motility, viability, and count | [155] | |||
Vitamin E | In-vivo | Chicken | 0, 20, 40, 80, 160 mg/kg | Higher sperm viability and motility (40–160 mg/kg) Higher sperm concentration (80 mg/kg) |
[44] |
200 mg/kg diet | Increased both sperm count and motility Reduced percentage of dead sperm |
[78] | |||
Human | 600 mg/d | Significant improvement in in-vitro sperm function | [75] | ||
100 mg/d | Significantly higher sperm motility Significantly decreased MDA levels |
[77] | |||
Vitamins C & E | In-vivo | Human | 1,000 mg/d 800 mg/d |
Increased ejaculate volume, sperm count, and motility | [81] |
1,000 mg/d | Markedly reduced DNA-fragmented sperm | [82] | |||
In-vitro | Human | 10 mM | Minimum improvement in sperm motility | [31] | |
Vitamins C & E, CAT, Hypotaurine, Cysteine, GSH | In-vitro | Human | 0.2 and 1 mM 2,600 U/mL 1 & 10 mM 1 & 10 mM 1 & 10 mM |
Protects against OS | [83] |
Vitamins C & E, GSH | In-vitro | Human | 200 mg, 200 mg, 400 mg | Reduced OS | [84] |
Vitamins C & E, Urate, Cysteine | In-vitro | Human | 300, 600 μM 30, 60 μM 200, 400 μM 5, 10 μM |
Improved sperm DNA integrity | [74] |
Mesterolone & Vitamin C | In-vivo | Human | 50 mg 200 mg |
No improvement in male fertility | [86] |
Cysteine, Vitamin A, & Vitamin E | In-vivo | Human | 600 mg/d 30 and 180 mg/d |
Neutralized the ROS and improve sperm count No effect on sperm motility |
[85] |
Selenium | In-vivo | Human | 100 μg/d | Significant rise in plasma selenium concentration and sperm motility | [156] |
400 U/d 200 μg/d |
Significantly higher sperm motility, viability, and fertility | [87] | |||
400 mg/d 225 μg/d |
Significantly improved sperm motility Significantly decreased MDA levels |
[76] | |||
Rebamipide | In-vitro | Human | 10, 30, 100, 300 μM | Decreased ROS level and LPO No effect on sperm viability |
[80] |
Taurine | In-vitro | Sheep | 0, 10, 20, 40, 80, 100 mM | Reduced LPO and improved semen parameters | [93] |
Cat | 50 mM | Higher sperm motility, Reduced abnormal sperms with sperm defects | [94] | ||
Stallion | 70, 100 mM | Improved sperm survival | [95] | ||
Donkey | 0, 20, 40, 60 mM | Significantly improved sperm motility | [96] | ||
Hamster | 0, 2×10−3, 2×10−4, 2×10−5 M | Improved motility and promote capacitation | [90] | ||
Hypotaurine | In-vitro | Hamster | 10 mM | Restore sperm motility and viability | [92] |
Taurine & Hypotaurine | In-vitro | Rabbit | 0.5 mM | Reduced LPO and restored motility | [91] |
Taurine & Trehalose | In-vitro | Cattle Bull | 50 mM 100 mM |
Significantly improved freeze-thaw motility, viability, and plasma membrane integrity | [97] |
Buffalo Bull | 50 mM 100 mM |
Improved motility, viability, and membrane integrity Low numbers of capacitated sperm |
[88] | ||
Taurine, QR, & GSH | In-vitro | Ram | 40 mM, 5 μg/mL, 5 mM | Reduced LPO Improved freeze-thaw semen quality |
[98] |
CoQ10 | In-vivo | Human | 200 mg/d | Improved sperm concentration, progressive motility, total motility, and semen antioxidant status Reduced ROS level and SDF percentage |
[100] |
Stallion | 1 gm/d | Improved semen quality | [110] | ||
In-vivo & In-vitro | Human | 5, 50 μM 60 mg |
Improved sperm motility and fertilization rate | [157] | |
Buffalo bull | 30 Mm | Improved sperm parameters and fertility | [105] | ||
Rooster | 0, 1, 2, 5, 10 μM | Significantly higher total sperm, progressive motilities, membrane functionality, viability, and mitochondria active potential Reduced LPO |
[104] | ||
Buck | 0, 0.5, 1, 1.5 μM | Improved sperm motility, viability, and plasma membrane functionality | [106] | ||
Giant grouper | 0, 25, 50, 100 μM | Improved total sperm motility, fertilization rate, and reduced DNA fragmentation | [103] | ||
Boar | - | Increase the sperm characteristics and prolong the survival of liquid storage of sperm | [108] | ||
Stallion | 40 & 80 μg/mL | No notable effect of semen quality | [109] | ||
CoQ10 & L-carnitine | In-vivo | Rat | 10 mg/kg/d 350 mg/kg/d |
Significantly improved sperm quality and hormonal profile by weakening the high and oxidized LDL | [102] |
CoQ10 & Ellagic acid | In-vitro | Ram | 0.5 μM 0.25 mM |
Higher total sperm, progressive motility, and viability No effect of sperm antioxidant level |
[107] |
GSH, glutathione; SOD, superoxide dismutase; BSA, bovine serum albumin; LPO, lipid peroxidation; ROS, reactive oxygen species; OS, oxidative stress; MDA, malondialdehyde; QR, quercetin; Q10, coenzyme; SDF, sperm DNA fragmentation; LDL, low density lipoprotein.